Estimation of efficacy and safety of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in recurrent or metastatic breast cancer patients

被引：0
|
作者：
Kang, S. S. [1 ]
Lee, H. [1 ]
Hur, M. [1 ]
Ko, S. [1 ]
Yoon, C. [1 ]
Kang, S. [1 ]
Roh, J. [2 ]
机构：
[1] Dankook Univ, Cheil Gen Hosp, Surg, Seoul, South Korea
[2] Dankook Univ, Cheil Gen Hosp, Med Oncol, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
368
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [21] Superior efficacy of a Cremophor-free albumin-bound paclitaxel compared with solvent-based paclitaxel in Chinese patients with metastatic breast cancer (vol 3, pg 165, 2009)
    Guan, Zhong-Zhen
    Li, Qing Li
    Feng, Fengyi
    Jiang, Zefei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (01) : 74 - 74
  • [22] Cremophor EL-free formulation of paclitaxel: A randomized, multicenter, safety, and efficacy study of nanosomal paclitaxel lipid suspension (NPLS) versus paclitaxel in women with metastatic breast cancer (MBC)
    Ahmad, Ateeq
    Sheikh, Saifuddin
    Mehta, Ajay O.
    Nagarkar, Rajnish Vasant
    Srinivasan, Krishnan
    Majumdar, Anup
    Mukherjee, Kalyan Kusum
    Singh, Jitendra K.
    Shrivastav, S. P.
    Satheesh, C. T.
    Maksud, Tanveer
    Pawar, Suraj
    Sonawane, Satish Ramkrishna
    Kamat, Satish V.
    Sharma, Manish
    Rane, R. C.
    Ahmad, Imran
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)
    Lee, Shin-Wha
    Kim, Yong-Man
    Cho, Chi Heum
    Kim, Young Tae
    Kim, Seok Mo
    Hur, Soo Young
    Kim, Jae-Hoon
    Kim, Byoung-Gie
    Kim, Seung-Cheol
    Ryu, Hee-Sug
    Kang, Soon Beom
    CANCER RESEARCH AND TREATMENT, 2018, 50 (01): : 195 - 203
  • [24] A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
    Ahn, Hee Kyung
    Jung, Minkyu
    Sym, Sun Jin
    Shin, Dong Bok
    Kang, Shin Myung
    Kyung, Sun Young
    Park, Jeong-Woong
    Jeong, Sung Hwan
    Cho, Eun Kyung
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 277 - 282
  • [25] An Open-Label, Randomized, Parallel, Phase Ill Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
    Park, In Hae
    Sohn, Joo Hyuk
    Kim, Sung Bae
    Lee, Keun Seok
    Chung, Joo Seop
    Lee, Soo Hyeon
    Kim, Tae You
    Jung, Kyung Hae
    Cho, Eun Kyung
    Kim, Yang Soo
    Song, Hong Suk
    Seo, Jae Hong
    Ryoo, Hun Mo
    Lee, Sun Ah
    Yoon, So Young
    Kim, Chul Soo
    Kim, Yong Tai
    Kim, Si Young
    Jin, Mi Ryung
    Ro, Jungsil
    CANCER RESEARCH AND TREATMENT, 2017, 49 (03): : 569 - 577
  • [26] A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
    Hee Kyung Ahn
    Minkyu Jung
    Sun Jin Sym
    Dong Bok Shin
    Shin Myung Kang
    Sun Young Kyung
    Jeong-Woong Park
    Sung Hwan Jeong
    Eun Kyung Cho
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 277 - 282
  • [27] Efficacy and dose-dependent activity of ABI-007; a cremophor-free, nanoparticle paclitaxel, in first-line metastatic breast cancer: integrated results of 2 phase II trials.
    Ibrahim, NK
    Samuels, B
    Page, R
    Guthrie, T
    Doval, D
    Patel, K
    Nair, M
    Digumarti, R
    Hortobagyi, GN
    Rao, S
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S131 - S131
  • [28] A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel
    Vergote, I
    Bergfeldt, K.
    Franquet, A.
    Lisyanskaya, A. S.
    Bjermo, H.
    Heldring, N.
    Buyse, M.
    Brize, A.
    GYNECOLOGIC ONCOLOGY, 2020, 156 (02) : 293 - 300
  • [29] An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)
    Lee, Shin-Wha
    Kim, Yong-Man
    Kim, Young Tae
    Kang, Soon Beom
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (03)
  • [30] Evaluating efficacy and safety of paclitaxel polymeric micelle regimen in advanced and metastatic NSCLC patients in Hai Phong Oncology Centre Vietnam.
    Nguyen Lam Hoa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345